Home › Full circle: Startup scores big deal with Pfizer - and QB3 is happy
 

Keywords :   


Full circle: Startup scores big deal with Pfizer - and QB3 is happy

2014-09-22 23:25:58| Biotech - Topix.net

David Earp, a former Geron executive, started with with Circle Pharma as an advisor through at QB3 program. He became president and CEO in October 2013, overseeing the company in its collaborations with Pfizer Inc. Startup Circle Pharma Inc., a UCSF and UC Santa Cruz spinout devising ways to disrupt a wide variety of diseases from inside cells, will work with Pfizer Inc. on two drug programs.

Tags: is full big happy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
02.07Ecolab Launches 100% Plastic-Free Wipe for Healthcare Settings
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Chattanooga Area High School Students Graduate from BASFs TECH Academy
More »